Naldi Luigi, Chatenoud Liliane, Belloni Anna, Peserico Andrea, Balato Nicola, Virgili Anna Rosa, Bruni Pier Luigi, Ingordo Vito, Lo Scocco Giovanni, Solaroli Carmen, Schena Donatella, Di Landro Anna, Pezzarossa Enrico, Arcangeli Fabio, Gianni Claudia, Betti Roberto, Carli Paolo, Farris Alessandro, Barabino Gian Franco, La Vecchia Carlo, Parazzini Fabio
Centro Studi GISED, Ospedali Riuniti di Bergamo, Bergamo, Italy.
Dermatology. 2008;216(2):125-30; discussion 130-2. doi: 10.1159/000111509. Epub 2008 Jan 23.
BACKGROUND/AIMS: To evaluate the association of psoriasis with selected medical conditions and a number of drugs used before diagnosis.
Multicenter case-control study involving outpatient services of 20 general and teaching hospitals. Entry criteria for cases were a first diagnosis of psoriasis made by a dermatologist and a history of skin manifestations of no more than 2 years after the reported onset of the disease. Controls were the first eligible dermatological patients observed on randomly selected days in the same centers as cases. A total of 560 cases and 690 controls were recruited.
The odds ratio (OR) of psoriasis was 0.8 (95% confidence interval, CI, 0.5-1.3) in hypertensive subjects, 1.1 (95% CI 0.6-2.0) in diabetics and 1.1 (95% CI 0.7-1.7) in hyperlipidemic subjects. Histamine 2 receptor antagonist exposure was negatively associated with psoriasis: OR 0.3 (95% CI 0.1-0.8).
Our study rules out a strong association of psoriasis at its first ever diagnosis with common chronic conditions. The reported associations of psoriasis with relatively common conditions such as diabetes mellitus, hypertension and hyperlipidemia may represent a late effect of well-known risk factors for psoriasis such as smoking and overweight or reflect factors related to the long course of psoriasis itself.
背景/目的:评估银屑病与特定疾病及诊断前使用的多种药物之间的关联。
多中心病例对照研究,涉及20家综合医院和教学医院的门诊服务。病例的入选标准为皮肤科医生首次诊断为银屑病,且自报告发病后皮肤表现病史不超过2年。对照为在与病例相同中心随机选定日期观察到的首批符合条件的皮肤科患者。共招募了560例病例和690例对照。
高血压患者中银屑病的比值比(OR)为0.8(95%置信区间,CI,0.5 - 1.3),糖尿病患者中为1.1(95%CI 0.6 - 2.0),高脂血症患者中为1.1(95%CI 0.7 - 1.7)。组胺2受体拮抗剂暴露与银屑病呈负相关:OR 0.3(95%CI 0.1 - 0.8)。
我们的研究排除了银屑病首次诊断时与常见慢性病的强关联。银屑病与糖尿病、高血压和高脂血症等相对常见疾病的报道关联可能代表了银屑病已知危险因素(如吸烟和超重)的晚期效应,或反映了与银屑病本身病程相关的因素。